君实宣布亏损收窄,老牌PD-1还能一战?

健识局
21 Jan

图源:君实生物1月17日晚,君实生物披露了2024年度业绩预告。经财务部门初步预算,2024年实现营业收入约19.49亿元,同比增长29.71%左右;净利润亏损12.92亿元,同比收窄超4成。尽管财务层面有好消息,投资者情绪还算冷静,1月20日,公司股价微涨1.11%。2024年,君实生物通过提质增效的确省了不少钱。据前三季度财报,公司管理费用降低了1.7%;业绩预告提到,公司研发费用同比减少了...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10